IVF

How soon after returning from IVF can you exercise depends on the egg retrieval and transfer stages. This article provides an exercise recovery timeline after egg retrieval, transfer, and pregnancy test, covering ovarian recovery, OHSS risk, exercise type selection, and a post-assisted reproduction surgery exercise guide.

The cumulative success rate of IVF in China is one of the most concerning issues for patients. Based on data from the assisted reproduction industry and real consultation scenarios, this article analyzes the differences in cumulative success rates across different age groups and hospitals, clarifies common misconceptions, and helps patients set realistic expectations.

Down syndrome can be screened through embryo testing using China's third-generation IVF technology (PGT-A), which detects aneuploidy of chromosome 21. It is indicated for advanced maternal age, recurrent miscarriage, history of chromosomal abnormality pregnancy, etc. The screening process includes embryo biopsy and genetic analysis, but PGT-A cannot replace prenatal diagnosis; amniocentesis is still required after transfer for confirmation.

Are China IVF hospital rankings reliable? This article analyzes the logic behind rankings from a medical perspective, teaching you how to evaluate reproductive centers based on core indicators such as qualifications, success rates, and laboratory standards, avoiding misleading marketing rankings.

Are there really many Chinese patients for IVF in Thailand? This article objectively analyzes the actual number and distribution characteristics of Chinese people seeking IVF in Thailand from dimensions such as reproductive center type, period changes, and patient structure, providing real references for families considering cross-border assisted reproduction.

An objective analysis of the applicable populations, cost differences, process distinctions, and potential risks of IVF agency versus self-service models in China. Provides a reference logic for selection based on factors such as age, budget, and time/energy.

China's IVF legal protection is based on regulations such as the 'Administrative Measures on Human Assisted Reproductive Technology' and 'Technical Standards for Human Assisted Reproductive Technology', which clearly define medical institution qualifications, patient indications, embryo protection principles, and privacy protection measures. This article analyzes the legal framework, patient rights, common legal issues, and medical visit precautions from a clinician's perspective.

China's IVF success rate data has statistical differences. Different reproductive centers use varying standards for clinical pregnancy rate and live birth rate. Age, embryo grade, and hospital qualification are core variables affecting the true success rate. This article interprets the real meaning of success rate data from the perspectives of statistical methods, industry standards, and individual differences, helping patients correctly understand the data and make rational choices.

Clinical data from Chinese assisted reproductive technology shows that female age is the most critical factor affecting IVF success rates. The success rate is approximately 50-60% for women under 35, dropping to below 20% for those over 40, and less than 5% for those over 45. This article explains from a reproductive medicine perspective the specific impacts of age on egg quality, embryo chromosomal abnormality rates, and endometrial receptivity, helping patients set realistic expectations.

As of 2025, provinces and cities including Beijing, Zhejiang, Shanghai, Guangdong, Jiangsu, Sichuan, Shandong, Hunan, Guangxi, Gansu, and Inner Mongolia have included some IVF procedures in medical insurance. Reimbursement rates vary from 30% to 70%, with differences in covered items and conditions. This article provides a detailed policy summary and interpretation.

Georgia is one of the few countries where assisted reproduction is legally open. Successful IVF cases for Chinese patients do exist, but numbers are limited and influenced by factors such as age, hospital choice, and legal procedures. Based on industry experience, this article analyzes real cases, legal background, procedures, and risks to help rationally assess whether IVF in Georgia is suitable for you.

In China, most public hospital reproductive centers are only open on weekend mornings or closed, while some top-tier hospitals offer Saturday morning check-ups; private hospitals typically see patients all weekend. Specific times require phone confirmation to avoid wasted trips. This article details weekend visit precautions, test scheduling, and special case handling.

During IVF in China, about 70%-80% of patients experience moderate to severe psychological stress, primarily from anxiety during the embryo transfer waiting period, physical burden of ovarian stimulation, frustration after repeated failure, and family expectations. Stress sources vary significantly by age. Scientific coping includes cognitive behavioral therapy, mindfulness-based stress reduction, and medication intervention when necessary.

The IVF success rate for women under 35 is typically between 50%‑65%, with a live birth rate of about 45%‑55%. Based on clinical data, this article analyzes age advantages, key examination indicators, and practical methods to improve success rates, helping young patients set reasonable expectations.

Analyze the proportion of out-of-town IVF patients in China and the current medical access situation. Data shows that in large domestic reproductive centers, out-of-town patients can account for 30%-60%, mainly influenced by technical level, policy restrictions, and successful cases. Cities like Beijing, Shanghai, and Guangzhou concentrate a large number of patients seeking medical care from other regions.

Interpretation of the two meanings of 'bringing parents' in China's IVF treatment: whether sperm or eggs (gametes) provided by parents can be used, and the actual situation of parents accompanying the visit. Clarify the restrictions of Chinese law and ethics on gamete sources, as well as hospital regulations on accompanying personnel.

What rights do Chinese IVF patients have by law? This article systematically outlines the legal rights, common misconceptions, and practical considerations for assisted reproduction patients, covering informed consent, privacy protection, embryo disposition, and autonomous choice.

IVF in Chinese public hospitals is mainly suitable for couples diagnosed with infertility who meet the national assisted reproductive technology准入 standards. This article details the medical indications, age requirements, document conditions, and unsuitable groups for public hospital IVF, helping to determine if it is suitable for IVF treatment in a public hospital.

A comprehensive analysis of China's IVF legal protection system, covering the regulatory framework of the 'Administrative Measures for Human Assisted Reproductive Technology', eligibility criteria, required documents, medical institution qualifications, embryo protection clauses, surrogacy bans, and other core content, helping families preparing for pregnancy understand legal boundaries and their rights.

After more than 30 years of development, IVF technology in China has reached a mature stage. Under strict regulation by the National Health Commission, the clinical pregnancy rate at正规 reproductive centers is stable at 40%-60%. Technical reliability depends on three core factors: the qualification of the medical institution, the patient's age and ovarian function, and the degree of individualization of the treatment plan. This article provides an objective analysis from dimensions such as clinical data, hospital differences, age stratification, and cost composition, helping patients build correct understanding and make rational choices.